ArticleFrontiers in oncology2020

Real-World Data of Triplet Combination of Trastuzumab, Lapatinib, and Chemotherapy in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study.

Yi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.